Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | €995.50 | €1,064.7 | 6.950% |
| Boston Scientific | 77 | 0 | 11 | 0 | €39.40 | €83.22 | 111.221% |
| UnitedHealth Group Inc. | 77 | 3 | 13 | 0 | €365.80 | €369.41 | 0.988% |
| Abbott Laboratories | 69 | 0 | 10 | 0 | €89.68 | €114.37 | 27.532% |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | €113.50 | €128.14 | 12.903% |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | €47.50 | €79.22 | 66.780% |
| Insmed Inc. | 63 | 1 | 4 | 0 | €87.50 | €173.11 | 97.845% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €143.75 | €305.21 | 112.319% |
| Neurocrine Bioscience | 57 | 0 | 5 | 0 | €148.60 | €159.17 | 7.116% |
| Johnson & Johnson | 56 | 0 | 12 | 0 | €221.00 | €227.33 | 2.862% |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | €344.60 | €435.61 | 26.412% |
| Dexcom Inc. | 52 | 2 | 3 | 0 | €72.00 | €73.67 | 2.319% |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | €416.95 | €467.05 | 12.015% |
| Alnylam Pharmace. | 46 | 0 | 6 | 0 | €177.95 | €430.54 | 141.945% |
| Regeneron Pharmaceuticals Inc. | 44 | 0 | 5 | 0 | €641.40 | €728.65 | 13.603% |
| Tenet Healthcare | 44 | 0 | 12 | 0 | €220.00 | €217.45 | -1.159% |
| AbbVie Inc. | 43 | 0 | 10 | 0 | €221.00 | €228.85 | 3.553% |
| Biogen Inc. | 43 | 1 | 10 | 1 | €178.18 | €200.07 | 12.283% |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | €224.20 | €224.09 | -0.051% |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | €69.76 | €81.13 | 16.299% |
| Medtronic plc | 41 | 1 | 2 | 0 | €74.00 | €97.41 | 31.628% |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | €91.50 | €116.89 | 27.747% |
| Amgen Inc. | 36 | 2 | 2 | 0 | €333.40 | €332.22 | -0.355% |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | €120.30 | €137.44 | 14.248% |
| Cigna Corp. | 32 | 0 | 0 | 0 | €252.10 | €288.04 | 14.256% |